Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes

Toxicological Sciences

Volumn 43, Issue 2, 1998, Pages 172-185

  Heo, Yong ^a   Lee, William T ^a   Lawrence, David A ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

Cellular activation; Cellular differentiation; Lead; Signal transduction; Th1; Th2

Indexed keywords

ADENYLATE CYCLASE; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; IONOMYCIN; KT 5720; LEAD; OVALBUMIN; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEAVY METAL POISONING; LEAD POISONING; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0031926863     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1006/toxs.1998.2457     Document Type: Article

References (61)

1. - single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor Vβ family. Proc. Natl. Acad. Sci. USA 89, 6506-6510.
2. Bendelac, A., Matzinger, P., Sedar, R. A., Paul, W. E., and Schwartz, R. H. (1992). Activation events during thymic selection. J. Exp. Med. 175, 731-742.
3. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108-113.
4. Borger, P., Kauffman, H. F., Postma, D. S., and Vellenga, E. (1996). Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood 87, 691-698.
5. Darnell, J. E., Kerr, I. M., and Stark, G. R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
6. Durbin, J. E., Hackenmiller, R., Simon, M. C., and Levy, D. E. (1996). Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
7. Freeman, G. J., Boussiotos, V. A., Anumanthan, A., Bernstein, G. M., Ke, X-Y., Rennert, P. D., Gray, G. S., Gribben, J. G., and Nadler, L. M. (1995). B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523-532.
8. Gajewski, T. F., and Fitch, F. W. (1991). Differential activation of murine Th1 and Th2 clones. Res. Immunol. 142, 19-23.
9. Gajewski, T. F., Pinnas, M., Wong, T., and Fitch, F. W. (1991). Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell population. J. Immunol. 146, 1750-1758.
10. Goldman, M., Druet, P., and Gleichmann, E. (1991). TH2 cells in systemic autoimmunity: Insights from allogeneic diseases and chemically-induced autoimmunity. Immunol. Today 12, 223-227.
11. Gordon, J. R., Burd, P. R., and Galli, S. J. (1990). Mast cells as a source of multifunctional cytokines. Immunol. Today 11, 458-464.
12. Güler, M. L., Gorham, J. D., Hiseh, C-S., Mackey, A. J., Steen, R. G., Dietrich, W. F., and Murphy, K. M. (1996). Genetic susceptibility to Leishimania: IL-12 responsiveness in TH1 cell development. Science 271, 984-987.
13. Guo, T. L., Mudzinski, S. P., and Lawrence, D. A. (1996). Regulation of HLA-DR and invariant chain expression by human peripheral blood mono-nuclear cells with lead, interferon-γ, or interleukin-4. Cell. Immunol. 171, 1-9.
14. Henttinen, T., Levy, D. E., Silvennoinen, O., and Hurme, M. (1995). Activation of the signal transducer and transcription (STAT) signaling pathway in a primary T cell response. J. Immunol. 155, 4582-4587.
15. Heo, Y., Lee, W. T., and Lawrence, D. A. (1997). In vivo the environmental pollutants lead and mercury induce oligoclonal T cell responses skewed toward Type-2 reactivities. Cell. Immunol. 179, 185-195.
16. Heo, Y., Parsons, P. J., and Lawrence, D. A. (1996). Lead differentially modifies cytokine production in vitro and in vivo. Toxicol. Appl. Pharmacol. 138, 149-157.
17. 2 critically depends on interleukin-2. Eur. J. Immunol. 25, 59-63.
18. Hsieh, C-S., Heimberger, A. B., Gold, J. S., O'Garra, A., and Murphy, K. M. (1992). Differential regulation of T helper phenotype development by interleukin 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89, 6065-6069.
19. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
20. Kaplan, M. H., Schindler, U., Smiley, S. T., and Grusby, M. J. (1996). Stat6 is required for mediating responses to IL-4 and for the development of the Th2 cells. Immunity 4, 313-319.
21. Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahashi, M., Murakata, C., Sato, A., and Kaneko, M. (1987). K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142, 436-440.
22. + T cells inhibits acquisition of ability to produce IFNγ and IL-2, but not IL-4 and IL-5. J. Immunol. 155, 4604-4612.
23. Kishikawa, H., Song, R., and Lawrence, D. A. (1997). Interleukin-12 promotes enhanced resistance to Listeria monocytogenes infection of lead-exposed mice. Toxicol. Appl. Pharmacol. 147, 180-189.
24. Kowolenko, M., Tracy, L., Mudzinski, S., and Lawrence, D. A. (1988). Effects of lead on macrophage function. J. Leukocyte Biol. 43, 357-364.
25. Kubo, M., Ransom, J., Webb, D., Hashimoto, Y., Tada, T., and Nakayama, T. (1997). T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. EMBO J. 16, 4007-4020.
26. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., and Glimcher, L. H. (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80, 707-718.
27. Kurt-Jones, E. A., Hamberg, S., Ohara, J., Paul, W. E., and Abbas, K. (1987). Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness. J. Exp. Med. 166, 1774-1787.
28. Lawrence, D. A., and McCabe, M. J. (1995). Immune modulation by toxic metals. In Metal Toxicology (R. A. Goyer, C. D. Klaassen, and M. P. Waalkes, Eds.), pp. 305-337. Academic Press, San Diego, CA.
29. Lee, H. J., Koyano-Nakagawa, N., Naito, Y., Nishida, J., Arai, N., Arai, K., and Yokota, T. (1993). cAMP activates the IL-5 promotor synergistically with phorbol ester through the signaling pathway involving protein kinase A in mouse thymoma line EL-4. J. Immunol. 151, 6135-6142.
30. Lenschow, D. J., Herold, K. C., Rhee, L., Patel, B., Koons, A., Qin, H-Y., Fuchs, E., Singh, B., Thompson, C. B., and Bluestone, J. A. (1996). CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5, 285-293.
31. Lucey, D. R., Clerici, M., and Shearer, G. M. (1996). Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9, 532-562.
32. + T cells. J. Immunol. 154, 5071-5079.
33. + T cell subsets. Toxicol. Appl. Pharmacol. 111, 13-23.
34. McCabe, M. J., Dias, J. A., and Lawrence, D. A. (1991). Lead influences translational or posttranslational regulation of 1a expression and increases invariant chain expression in mouse B cells. J. Biochem. Toxicol. 6, 269-276.
35. Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., and Schreiber, R. D. (1996). Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442.
36. Mond, J. J., Carman, J., Sarma, C., Ohara, J., and Finkelman, F. D. (1986). Interferon-γ suppresses B cell stimulation factor (BSF-1) induction of Class II MHC determinants on B cells. J. Immunol. 137, 3534-3537.
37. Muñoz, E., Zubiaga, A. M., Merrow, M., Sauter, N. P., and Huber, B. T. (1990a). Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation:Role of cAMP in T cell proliferation. J. Exp. Med. 172, 95-103.
38. Muñoz, E., Zubiaga, A. M., Muñoz, J., and Huber, B. T. (1990b). Regulation of IL-4 lymphokine gene expression and cellular proliferation in murine T helper type II cells. Cell Regul. 1, 425-434.
39. 2 may reside downstream of the PKC-dependent pathway. Cytokine 8, 346-356.
40. Novak, T. J., and Rothenberg, E. V. (1990). CAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 87, 9353-9357.
41. Oliveira, D. B. G., Gillespie, K., Wolfreys, K., Mathieson, P. W., Qasim, F., and Coleman, J. W. (1995). Compounds that induce autoimmunity in the Brown Norway rat sensitize mast cells for mediator release and interleukin-4 expression. Eur. J. Immunol. 25, 2259-2264.
42. Pelletier, L., Castedo, M., Bellon, B., and Druet, P. (1994). Mercury and autoimmunity. In Immunotoxicology and Immunopharmacology (J. H. Dean, M. I. Luster, A. E. Munson, and H. Amos, Eds.), pp. 539-552. Raven Press, New York.
43. Prigent, P., Saoudi, A., Pannetier, C., Graber, P., Bonnefoy, J. Y., Druet, P., and Hirsch, F. (1995). Mercuric chloride, a chemical responsible for T helper cell (Th2)-mediated autoimmunity in Brown Norway rats, directly triggers T cells to produce interleukin-4. J. Clin. Invest. 96, 1484-1489.
44. Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., and Sinigaglia, F. (1997). Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185, 825-831.
45. Rulifson, I. C., Sperling, A. I., Field, P. E., Fitch, F. W., and Bluestone, J. A. (1997). CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158, 658-665.
46. + cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J. Immunol. 155, 4844-4853.
47. Schmidt, J., Hatzelmann, A., Fleißner, S., Heimann-Weitschat, I., Lindstaedt, R., and Szelenyi, I. (1995). Effect of phosphodiesterase inhibition on IL-4 and IL-5 production of the murine TH2-type T cell clone D10.G4.1. Immunopharmacology 30, 191-198.
48. Sears, M. R., Burrows, B., Flannery, E. M., Herbison, G. P., Hewitt, C. J., and Holdaway, M. D. (1991). Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N. Engl. J. Med. 325, 1067-1071.
49. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90, 10188-10192.
50. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176, 1091-1098.
51. Shimoda, K., Deursen, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A. A., Doherty, P. C., Grosveld, G., Paul, W. E., and Ihle, J. N. (1996). Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633.
52. Swain, S. L., Bradley, L. M., Croft, M., Tonkonogy, S., Atkins, G., Weinberg, A. D., Duncan, D. D., Hedrick, S. M., Dutton, R. W., and Huston, G. (1991). Helper T-cell subsets: Phenotype, function and role of lymphokines in regulating their development. Immunol. Rev. 123, 115-144.
53. Swain, S. L., Weinberg, A. D., English, M., and Huston, G. (1990). IL-4 directs the development to Th2-like helper effectors. J. Immunol. 145, 3796-3806.
54. Szabo, S. J., Jacobson, N. G., Dighe, A. S., Gubler, U., and Murphy, K. M. (1995). Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2, 665-675.
55. Tian, L., and Lawrence, D. A. (1995). Lead inhibits nitric oxide production in vitro by murine splenic macrophages. Toxicol. Appl. Pharmacol. 132, 156-163.
56. 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181, 775-779.
57. Tony, H. P., Phillips, N. E., and Parker, D. C. (1985). Role of membrane immunoglobulin (lg) crosslinking in membrane lg-mediated, major histocompatibility-restricted T cell-B cell cooperation. J. Exp. Med. 162, 1695-1708.
58. Tsuruta, L., Lee, H-J., Masuda, E. S., Koyano-Nakagawa, N., Arai, N., Arai, K., and Yokota, T. (1995). Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP. J. Immunol. 154, 5255-5264.
59. Warner, G. L., and Lawrence, D. A. (1986). Stimulation of murine lymphocyte response by cations. Cell. Immunol. 101, 425-439.
60. + T lymphocytes. Res. Immunol. 142, 23-32.
61. pos T cells promptly produce interleukin 4 in response to in vitro challenge with anti-CD3. J. Exp. Med. 179, 1285-1295.